In the latest trading session, Eli Lilly (LLY) closed at $804.99, marking a -0.39% move from the previous day.
GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...
Wells Fargo lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,000 and keeps an Overweight rating on the shares. The firm ...
Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new ...
Bloomfield Hills internal medicine physician Amjad Rass was excited to reunite with family in Syria last month for the first ...